Related Experiment Video
Updated: Jan 31, 2026

Ultra-long Read Sequencing for Whole Genomic DNA Analysis
Published on: March 15, 2019
Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project
Stacey Pereira1, Jill Oliver Robinson1, Amanda M Gutierrez1
1Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas.
Insights
Parents and clinicians show varied confidence in genomic sequencing (GS) for newborns compared to newborn screening (NBS). While both see benefits, parents perceive a more favorable risk-benefit ratio for GS than clinicians do.
Area of Science:
- Genomics
- Pediatrics
- Bioethics
Background:
- Interest is growing in using genomic sequencing (GS) for newborn clinical care.
- Newborn screening (NBS) is the current standard for genetic disorder detection in infants.
Purpose of the Study:
- To explore parents' and clinicians' attitudes toward newborn genomic sequencing (GS).
- To compare perceptions of risks, benefits, and utility of GS versus newborn screening (NBS) in newborns.
Main Methods:
- The BabySeq Project, a randomized controlled trial, surveyed 493 parents and 144 clinicians.
- Attitudes and perceived risks/benefits of NBS and GS were assessed via baseline surveys.
- Open-ended responses regarding risks and benefits were thematically categorized.
Main Results:
- Most parents (71%) and clinicians (51%) agreed GS has health benefits.
- Parents perceived greater benefits and fewer risks of GS compared to clinicians.
- Clinicians expressed stronger concerns about privacy and discrimination risks associated with GS.
Conclusions:
- Parents and clinicians exhibit less confidence in GS than NBS.
- Parents hold a more optimistic view of GS's risk-benefit ratio than clinicians.
- Clinicians should recognize that parental optimism may stem from perceived benefits beyond direct clinical utility.
Background And Objectives:
There is interest in applying genomic sequencing (GS) to newborns' clinical care. Here we explore parents' and clinicians' attitudes toward and perceptions of the risks, benefits, and utility of newborn GS compared with newborn screening (NBS) prior to receiving study results.
Methods:
The BabySeq Project is a randomized controlled trial used to explore the impact of integrating GS into the clinical care of newborns. Parents (n = 493) of enrolled infants (n = 309) and clinicians (n = 144) completed a baseline survey at enrollment. We examined between-group differences in perceived utility and attitudes toward NBS and GS. Open-ended responses about risks and benefits of each technology were categorized by theme.
Results:
The majority of parents (71%) and clinicians (51%) agreed that there are health benefits of GS, although parents and clinicians agreed more that there are risks associated with GS (35%, 70%) than with NBS (19%, 39%; all P < .05). Parents perceived more benefit and less risk of GS than did clinicians. Clinicians endorsed concerns about privacy and discrimination related to genomic information more strongly than did parents, and parents anticipated benefits of GS that clinicians did not.
Conclusions:
Parents and clinicians are less confident in GS than NBS, but parents perceive a more favorable risk/benefit ratio of GS than do clinicians. Clinicians should be aware that parents' optimism may stem from their perceived benefits beyond clinical utility.
Related Concept Videos
Genomics
Benefits of Self-Esteem
Perceiving Loudness, Pitch, and Location
Place theory, or place coding, suggests that different pitches are heard because various sound waves activate specific locations along the cochlea's basilar membrane. The brain determines the pitch of a sound by...
Fischer Projections
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Newman Projections
The organic molecules rotate across the single bonds leading to numerous temporary three-dimensional structures of varying energy known as...

